261 related articles for article (PubMed ID: 23417837)
21. Transcriptional regulation of Wnt inhibitory factor-1 by Miz-1/c-Myc.
Licchesi JD; Van Neste L; Tiwari VK; Cope L; Lin X; Baylin SB; Herman JG
Oncogene; 2010 Nov; 29(44):5923-34. PubMed ID: 20697356
[TBL] [Abstract][Full Text] [Related]
22. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer.
Mazieres J; He B; You L; Xu Z; Lee AY; Mikami I; Reguart N; Rosell R; McCormick F; Jablons DM
Cancer Res; 2004 Jul; 64(14):4717-20. PubMed ID: 15256437
[TBL] [Abstract][Full Text] [Related]
23. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
24. WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia.
Roman-Gomez J; Jimenez-Velasco A; Cordeu L; Vilas-Zornoza A; San Jose-Eneriz E; Garate L; Castillejo JA; Martin V; Prosper F; Heiniger A; Torres A; Agirre X
Eur J Cancer; 2007 Dec; 43(18):2736-46. PubMed ID: 18032022
[TBL] [Abstract][Full Text] [Related]
25. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
26. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.
Gao Z; Xu Z; Hung MS; Lin YC; Wang T; Gong M; Zhi X; Jablon DM; You L
Anticancer Res; 2009 Jun; 29(6):2025-30. PubMed ID: 19528461
[TBL] [Abstract][Full Text] [Related]
27. Procaine and procainamide inhibit the Wnt canonical pathway by promoter demethylation of WIF-1 in lung cancer cells.
Gao Z; Xu Z; Hung MS; Lin YC; Wang T; Gong M; Zhi X; Jablons DM; You L
Oncol Rep; 2009 Dec; 22(6):1479-84. PubMed ID: 19885602
[TBL] [Abstract][Full Text] [Related]
28. Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.
Tan M; Wu J; Cai Y
Biochem Biophys Res Commun; 2013 Sep; 438(4):673-9. PubMed ID: 23939044
[TBL] [Abstract][Full Text] [Related]
29. Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer.
Guo Q; Wang HB; Li YH; Li HF; Li TT; Zhang WX; Xiang SS; Sun ZQ
Med Sci Monit; 2016 Aug; 22():2816-24. PubMed ID: 27506957
[TBL] [Abstract][Full Text] [Related]
30. Wnt inhibitory factor-1 functions as a tumor suppressor through modulating Wnt/β-catenin signaling in neuroblastoma.
Zhang J; Zhou B; Liu Y; Chen K; Bao P; Wang Y; Wang J; Zhou Z; Sun X; Li Y
Cancer Lett; 2014 Jun; 348(1-2):12-9. PubMed ID: 24561119
[TBL] [Abstract][Full Text] [Related]
31. CpG methylation of APC promoter 1A in sporadic and familial breast cancer patients.
Debouki-Joudi S; Trifa F; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
Cancer Biomark; 2017; 18(2):133-141. PubMed ID: 27983523
[TBL] [Abstract][Full Text] [Related]
32. Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas.
Yang Z; Wang Y; Fang J; Chen F; Liu J; Wu J; Wang Y
J Exp Clin Cancer Res; 2010 Mar; 29(1):26. PubMed ID: 20334650
[TBL] [Abstract][Full Text] [Related]
33. Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression.
Jin Z; Zhao C; Han X; Han Y
BMC Cancer; 2012 Oct; 12():480. PubMed ID: 23075330
[TBL] [Abstract][Full Text] [Related]
34. Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer.
Zhang H; Zhu YQ; Wu YQ; Zhang P; Qi J
World J Gastroenterol; 2014 May; 20(20):6329-35. PubMed ID: 24876755
[TBL] [Abstract][Full Text] [Related]
35. [Methylation Status and mRNA Expression of DKK-3 and WIF-1 in Acute Myeloid Leukemia Patients].
Xu MM; Yang YL; Geng YH; Li J; Ma Y; Zhang F; Zhu FB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1314-1320. PubMed ID: 29070101
[TBL] [Abstract][Full Text] [Related]
36. WNT5A expression in human breast cancer.
Leris AC; Roberts TR; Jiang WG; Newbold RF; Mokbel K
Anticancer Res; 2005; 25(2A):731-4. PubMed ID: 15868903
[TBL] [Abstract][Full Text] [Related]
37. Promoter methylation of WNT inhibitory factor-1 and expression pattern of WNT/β-catenin pathway in human astrocytoma: pathologic and prognostic correlations.
Kim SA; Kwak J; Nam HY; Chun SM; Lee BW; Lee HJ; Khang SK; Kim SW
Mod Pathol; 2013 May; 26(5):626-39. PubMed ID: 23328978
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic silencing of WIF-1 in hepatocellular carcinomas.
Deng Y; Yu B; Cheng Q; Jin J; You H; Ke R; Tang N; Shen Q; Shu H; Yao G; Zhang Z; Qin W
J Cancer Res Clin Oncol; 2010 Aug; 136(8):1161-7. PubMed ID: 20119713
[TBL] [Abstract][Full Text] [Related]
39. Does Wnt/β-catenin pathway contribute to the stability of DNMT1 expression in urological cancer cell lines?
Varol N; Konac E; Bilen CY
Exp Biol Med (Maywood); 2015 May; 240(5):624-30. PubMed ID: 25349215
[TBL] [Abstract][Full Text] [Related]
40. HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway.
Ge XS; Ma HJ; Zheng XH; Ruan HL; Liao XY; Xue WQ; Chen YB; Zhang Y; Jia WH
Cancer Sci; 2013 Dec; 104(12):1675-82. PubMed ID: 24118380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]